Teva Pharmaceutical Industries (002728.SZ) releases first half year financial report, net profit attributable to parent company shareholders reached RMB 38,007,700, an increase of 1313.23%.
Zhixin Finance APP News, Te Yi Pharmaceutical (002728.SZ) released its 2025 interim report, with the company's operating income at 491 million yuan, an increase of 56.54% year-on-year. Net profit attributable to shareholders of the listed company was 38.0077 million yuan, an increase of 1313.23% year-on-year. Net profit attributable to shareholders of the listed company after deducting non-recurring gains and losses was 38.0853 million yuan, an increase of 6095.52% year-on-year. Basic earnings per share were 0.08 yuan.
Latest